({1-[(2-amino-6-chloro-9H-purin-9-yl)methyl]cyclopropyl}oxy)methyl phosphonic acid | 441785-23-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: ({1-[(2-amino-6-chloro-9H-purin-9-yl)methyl]cyclopropyl}oxy)methyl phosphonic acid
• 英文别名: [1-[(2-Amino-6-chloro-purin-9-yl)methyl]cyclopropoxy]methylphosphonic acid；[1-[(2-amino-6-chloropurin-9-yl)methyl]cyclopropyl]oxymethylphosphonic acid
• CAS: 441785-23-5
• 化学式: C₁₀H₁₃ClN₅O₄P
• 分子量: 333.671
• InChiKey: MHNAKYHTAISYPF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  136
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  ({1-[(2-amino-6-chloro-9H-purin-9-yl)methyl]cyclopropyl}oxy)methyl phosphonic acid 在 盐酸 、 水 作用下， 反应 6.0h， 以95%的产率得到LB-80317
  参考文献：
  名称：

  [EN] NUCLEOSIDE PHOSPHONATE DERIVATIVES USEFUL IN THE TREATMENT OF HIV INFECTIONS
  [FR] DERIVES DE NUCLEOSIDE PHOSPHONATE UTILES DANS LE TRAITEMENT D'INFECTIONS VIH

  摘要：

  本发明涉及通过给予由式(I)表示的核苷酸膦酸衍生物来治疗HIV感染的方法。

  公开号：

  WO2005079812A1
• 作为产物：
  描述：

  [[[1-[[(甲基磺酰基)氧基]甲基]环丙基]氧基]甲基]膦酸二异丙酯 在 三甲基溴硅烷 、 sodium hydride 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 22.5h， 生成 ({1-[(2-amino-6-chloro-9H-purin-9-yl)methyl]cyclopropyl}oxy)methyl phosphonic acid
  参考文献：
  名称：

  A Novel Class of Phosphonate Nucleosides. 9-[(1-Phosphonomethoxycyclopropyl)methyl]guanine as a Potent and Selective Anti-HBV Agent

  摘要：

  9-[1-(Phosphonomethoxycyclopropyl)methyl]guanine (PMCG, 1), representative of a novel class of phosphonate nucleosides, blocks HBV replication with excellent potency (EC50 = 0.5 muM) in a primary culture of HepG2 2.2.15 cells. It exhibits no significant cytotoxicity in several human cell lines up to 1.0 mM. It does not inhibit replication of human immunodeficiency virus (HIV-1) or herpes simplex virus (HSV-1) at 30 muM. Many purine base analogues of 1 also exhibit inhibitory activity against HBV, but at 30 muM, pyrimidine analogues do not. 1 is 4 times more potent than 9- [2-(phosphonomethoxy)ethyl] adenine (PMEA), which was used as a positive control (EC50 = 2.0 muM). The characteristic cyclopropyl moiety at the 2'-position of 1 was prepared by titanium-mediated Kulinkovich cyclopropanation. 1 was modified to give the orally available drug candidate, PMCDG Dipivoxil (2). Compound 2 exhibited excellent efficacy when administered at 5 mg per kg per day in a study with woodchucks infected with woodchuck hepatitis B virus (WHBV). Drug candidate 2 has successfully completed phase I clinical trials and is currently undergoing phase II clinical studies for evaluation of efficacy.

  DOI：

  10.1021/jm0305265

文献信息

• [EN] NUCLEOSIDE PHOSPHONATE DERIVATIVES USEFUL IN THE TREATMENT OF HIV INFECTIONS<br/>[FR] DERIVES DE NUCLEOSIDE PHOSPHONATE UTILES DANS LE TRAITEMENT D'INFECTIONS VIH
  申请人：ANADYS PHARMACEUTICALS INC

  公开号：WO2005079812A1

  公开（公告）日：2005-09-01

  The present invention relates to a method of treating HIV infections by administering a nucleoside phosphonate derivative represented by formula (I).

  本发明涉及通过给予由式(I)表示的核苷酸膦酸衍生物来治疗HIV感染的方法。
• [EN] NEW PROCESS FOR PREPARING DIISOPROPYL ((1-((2-AMINO-6-CHLORO-9H-PURIN-9-YL)METHYL)CYCLOPROPYL)OXY)METHYLPHOSPHONATE<br/>[FR] NOUVEAU PROCEDE DE PREPARATION DE DIISOPROPYL((1-((2-AMINO-6-CHLORO-9H-PURIN-9-YL)METHYL)CYCLOPROPYL)OXY)METHYLPHOSPHONATE
  申请人：LG LIFE SCIENCES LTD

  公开号：WO2005058926A1

  公开（公告）日：2005-06-30

  The present invention relates to a new process for preparing the compound of formula (1) which is important intermediate for preparation of nucleoside analog of the compound of formula (2) effective as antiviral agent, in particular hepatitis B viral agent.

  本发明涉及一种用于制备化合物（1）的新工艺，该化合物是制备化合物（2）的重要中间体，化合物（2）是一种作为抗病毒剂，特别是肝炎B病毒制剂的核苷类似物的有效中间体。
• Nucleoside phosphonate derivatives useful in the treatment of HIV infections
  申请人：Averett R. Devron

  公开号：US20060052346A1

  公开（公告）日：2006-03-09

  The present invention relates to a method of treating HIV infections by administering a nucleoside phosphonate derivative represented by formula (1).

  本发明涉及通过给予由式（1）表示的核苷酸膦酸衍生物治疗HIV感染的方法。
• Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
  申请人：——

  公开号：US20040063668A1

  公开（公告）日：2004-04-01

  The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

  本发明涉及一种无环核苷酸膦酸酯衍生物，其可用作抗病毒剂（特别是对乙型肝炎病毒），药学上可接受的盐，立体异构体以及其制备方法。
• Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
  申请人：LG Life Sciences Ltd.

  公开号：US07157448B2

  公开（公告）日：2007-01-02

  The present invention relates to a nucleoside phosphonate derivative represented by formula (1): pharmaceutically acceptable salts, and stereoisomers. This nucleoside phosphonate derivative is useful as an antiviral agent, particularly, against hepatitis B virus. Also disclosed are processes for the preparation of the nucleoside phosphonate derivative. Also disclosed are methods treating hepatitis B by administering a nucleoside phosphonate derivative of formula (1).

  本发明涉及一种由公式（1）所表示的核苷酸膦酸衍生物：药学上可接受的盐和立体异构体。该核苷酸膦酸衍生物可用作抗病毒剂，特别是针对乙型肝炎病毒。还公开了制备该核苷酸膦酸衍生物的方法。还公开了通过给予公式（1）的核苷酸膦酸衍生物治疗乙型肝炎的方法。